Direction Générale de la Santé, France
9
2
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.4% vs industry average
33%
3 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment reporting
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Evaluation of the Effect of Light Therapy on the Evolution of Self-reported Depressive Disorders in Chronic Hemodialysis Patients
Role: collaborator
Impact of EDEN College Courses on the Quality of Life of Voice-Hearers
Role: collaborator
Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 in Patients Having to be Vaccinated MenBVac® (Extension EFFIVAC)
Role: collaborator
Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Vaccinated With MenBVac® (Extension MenbVac)
Role: collaborator
Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's Disease
Role: collaborator
CHLORDECONE EXPOSURE AND PROSTATE CANCER IN THE FRENCH REGION OF MARTINIIQUE
Role: collaborator
Polymorphism of the IgH Locus Regulatory Region as a Prognostic Factor During Immune Pathologies.
Role: collaborator
Impact of Vouchers and Nutrition Education on the Consumption of Fruits and Vegetables Among Vulnerable Families (FLAM)
Role: collaborator
Outpatient Versus Inpatient Detoxification Program for Alcohol Dependent Patients Seeking Abstinence: The IN/OUT Study
Role: collaborator
All 9 trials loaded